Clever Leaves Holdings Inc. (CLVR)
NASDAQ: CLVR · IEX Real-Time Price · USD
0.261
+0.013 (5.28%)
Jun 2, 2023, 11:43 AM EDT - Market open
Company Description
Clever Leaves Holdings Inc. operates as a cannabis company.
The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally.
The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States.
The company was founded in 2017 and is based in Boca Raton, Florida.
Clever Leaves Holdings Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 400 |
| CEO | Andres Fajardo |
Contact Details
Address:
Bodega 19-b Parque Industrial Tibitoc Ph Tocancipa - Cundinamarca, F8 251017 Colombia | |
| Phone | 561-634-7430 |
| Website | cleverleaves.com |
Stock Details
| Ticker Symbol | CLVR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819615 |
| CUSIP Number | 186760104 |
| ISIN Number | CA1867601041 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Andres Fajardo | Co-Founder, Chief Executive Officer and Director |
| Henry R. Hague III | Chief Financial Officer |
| Gustavo Escobar | Chief Operating Officer |
| David M. Kastin Esq. | General Counsel and Corporate Secretary |
| Diana Sigüenza | Strategic Communications Director |
| Amit Pandey | Executive Vice President of Finance |
| Julian Wilches | Chief Regulatory Officer |
| Andrew Miller | Head of Business Development |
| Camilo Bohorquez | Head of Colombia |
| Caroline Kliess | Managing Director of Germany |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 26, 2023 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 23, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| May 11, 2023 | 10-Q | Quarterly Report |
| May 11, 2023 | 424B3 | Prospectus |
| May 11, 2023 | 8-K | Current Report |
| Apr 19, 2023 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 18, 2023 | DEF 14A | Other definitive proxy statements |
| Apr 7, 2023 | EFFECT | Notice of Effectiveness |
| Apr 4, 2023 | POS AM | Post-Effective amendments for registration statement |
| Apr 3, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |